Ampersand Capital Partners has acquired NEOMED-LABS from the NEOMED Institute. No financial terms were disclosed. NEOMED-LABS is a provider of clinical immunology laboratory services for biologics drug development.
Swander Pace seals Fine Choice Foods sale to Power Sustainable Lios
5 minutes ago · 2 mins read
KKR to acquire IEP Technologies and Newson Gale from Hoerbiger
27 minutes ago · 2 mins read
Major League Baseball's private equity investors see growth beyond potential lockout
48 minutes ago · 6 mins read
HIG Capital acquires majority stake in Italian infrastructure services firm L4A
51 minutes ago · 2 mins read
Bregal Milestone backs Italian cybersecurity firm Nethive with majority investment
56 minutes ago · 2 mins read
EQT strikes €10.8bn deal to take Qiagen private at 40.3% premium
4 hours ago · 3 mins read
Broad Sky-backed Commonwealth Electrical relaunches as CET energy services platform
19 hours ago · 2 mins read
